Amersham's mystery suitor
8 October 2003

Broadlybased health groups such as Roche and Johnson & Johnson look the most likely acquirers for the £4.6bn UK medical group. Amersham could be attractive because it is market leader in two of its businesses, enjoys high barriers to entry and isn t that expensive.